Remdesivir has ‘no meaningful impact’ on COVID-19 survival, huge study finds
The antiviral drug remdesivir does not reduce deaths among COVID-19 patients, as compared with standard care, according to the results […]
» Read morenohealthproblemsnews.com
Home » (COVID-19) »
The antiviral drug remdesivir does not reduce deaths among COVID-19 patients, as compared with standard care, according to the results […] TUESDAY, Oct. 13, 2020 — A study to assess whether certain approved or experimental drugs are effective against COVID-19 and […] Seven months into the pandemic, it’s no secret that plenty of people still downplay the risks of COVID-19, scoffing at […] We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your […] Digestive issues have been commonly seen in patients who have recovered from Covid-19, which need to be addressed on time […] Save our loos! How council cuts to public conveniences is keeping thousands of Britons stuck at home out of fear […] A new paper in Nature Communications outlines how an international research team has identified potential ways forward to rapidly design […] What is dexamethasone and how could it help with coronavirus? Fox News medical contributor Dr. Marc Siegel on the latest […] The Consumer Technology Association and the Connected Health Initiative announced this morning a new multi-sector initiative of private tech companies, […] (HealthDay)—For admitted COVID-19 patients presenting to the same urban medical center, risk-adjusted outcomes were no worse for non-Hispanic Black and […]
Remdesivir has ‘no meaningful impact’ on COVID-19 survival, huge study finds
NIH Launches Trial of Antibody Drugs Against COVID-19
Don’t know any COVID-19 patients who’ve died or been in the hospital? That may explain a lot
Best supplements for winter months: A pill to reduce risk of flu, depression and COVID-19
Digestive troubles post-COVID: A gastroenterologist explains
How councils have closed down 300 toilets since Covid-19 outbreak
Research identifies new information to accelerate structure-based drug design against COVID-19
What is dexamethasone, the newest drug in Trump’s COVID-19 treatment?
Big tech, digital health coalition forms to undercut COVID-19 healthcare disparities
No race difference found in COVID-19 mortality rates at same medical center